Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study - 22/04/20

Alexandra Fisch, MD ^a, Lucas Morin, PhD ^{b, c}, Toomas Talme, MD, PhD ^d, Kristina Johnell, MScPharm, PhD ^{b, c}, Irène Gallais Sérézal, MD, PhD ^{d, e, ⁎}

^a Department of Dermatology, Gävle Hospital, Gävle, Sweden 

^b Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden 

^c Institut National de la Santé et de la Recherche Médicale 1431 Centre d'Investigation Clinique, University Hospital Besançon, Besançon, France 

^d Department of Dermatology and Venerology, Karolinska University Hospital, Stockholm, Sweden 

^e Department of Dermatology, Besançon University Hospital, Besançon, France 

^∗Correspondence to: Irène Gallais Sérézal, Department of Dermatovenerology, Karolinska University Hospital, 171 24 Stockholm, SwedenDepartment of DermatovenerologyKarolinska University HospitalStockholm171 24Sweden